Diagnosis and Treatment Algorythm in Lyme Neuroborreliosis

1. Stanek G, Fingerle V, Hunfeld KP, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. ClinMicrobiolInfect. 2011;17:69-79.10.1111/j.1469-0691.2010.03175.xSearch in Google Scholar

2. Mygland A, Ljostad U, Fingerle V, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol.2010;17:8-16.10.1111/j.1468-1331.2009.02862.xSearch in Google Scholar

3. Steere AC. Lyme disease. N Engl J Med. 2001;345:115-25.10.1056/NEJM200107123450207Search in Google Scholar

4. Halperin JJ. Neuroborreliosis. Am J Med. 1995;98(4):52-6.10.1016/S0002-9343(99)80044-8Search in Google Scholar

5. Kruger H, Reuss K, Pulz M, et al. Meningoradiculitis and encephalomyelitis due to Borreliaburgdorferi: a follow-up study of 72 patients over 27 years. J Neurol. 1989;236:322-8.10.1007/BF003143732795099Search in Google Scholar

6. Halperin JJ, Shapiro ED, Logigian E, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology.2007;69:91-102.10.1212/01.wnl.0000265517.66976.2817522387Search in Google Scholar

7. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089-134.10.1086/50866717029130Search in Google Scholar

8. Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990.A prospective study of 187 patients with Borreliaburgdorferi-specific intrathecal antibody production. Brain. 1992;115(Pt2):399-423.10.1093/brain/115.2.3991606475Search in Google Scholar

9. Ljostad U, Skarpaas T, Mygland A. Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol.2007;14(8):873-6.10.1111/j.1468-1331.2007.01799.x17662007Search in Google Scholar

10. Hammers-Berggren S, Hansen K, Lebech AM, Karlsson M. Borreliaburgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology.1993;43(1):169-75.10.1212/WNL.43.1_Part_1.1698423881Search in Google Scholar

11. Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology. 1991;41(10):1571-8210.1212/WNL.41.10.1571Search in Google Scholar

12. OschmannP, Dorndorf W, Hornig C, et al. Stages and syndromes of neuroborreliosis. J Neurol. 1998;245:262-72.10.1007/s0041500502169617706Search in Google Scholar

13. O’Connell S. Lyme borreliosis: current issues in diagnosis and management. CurrOpin Infect Dis. 2010;23(3):231-5.10.1097/QCO.0b013e32833890e220407371Search in Google Scholar

14. Skogman BH, Croner S, Nordwall M, et al. Lyme neuroborreliosis in children : a prospective study of clinical features, prognosis, and outcome.Pediatr Infect Dis J.2008;27(12):1089-94.10.1097/INF.0b013e31817fd42319008771Search in Google Scholar

15. SkeieGO, Eldoen G, Skeie BS, et al.Opsoclonus myoclonus syndrome in two cases with neuroborreliosis. Eur J Neurol. 2007;14(12): el-2.10.1111/j.1468-1331.2007.01959.x18028183Search in Google Scholar

16. Wormser GP, Dattwyler RJ, Shapiro ED et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of American. Clin Infect Dis. 2006;43(9):1089-1134.10.1086/50866717029130Search in Google Scholar

17. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis.Clin Microbiol Rev. 2005;18(3):484-509.10.1128/CMR.18.3.484-509.2005119597016020686Search in Google Scholar

18. Stanek G, Strle F. Lyme borreliosis- European perspective. Infect Dis Clin North Am. 2008;22(2):327-39.10.1016/j.idc.2008.01.00118452805Search in Google Scholar

19. Strle F, Stanek G. Clinical manifestations and diagnosis of Lyme borreliosis. Curr Probl Dermatol 2009;37:51-110.10.1159/00021307019367097Search in Google Scholar

20. Halperin J, Luft BJ, Volkman DJ, Dattwyler RJ. Lyme neuroborreliosis. Peripheral nervous system manifestations. Brain. 1990;113(Pt4):1207-21.10.1093/brain/113.4.12072168778Search in Google Scholar

21. Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borreliaburgdorferi-specific immunoglobulin G, A, and M. Ann Neurol. 1991;30(2):197-205.10.1002/ana.410300212Search in Google Scholar

22. Ljostad U,Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroboreliosis: a multicenter, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7(8):690-95.10.1016/S1474-4422(08)70119-4Search in Google Scholar

23. Kruger H, Reuss K, Pulz M, et al. Meningoradiculitis and encephalomyelitis due to Borreliaburgdorferi: a follow-up study of 72 patients over 27 years. J Neurol. 1989;236(6):322-28.10.1007/BF003143732795099Search in Google Scholar

24. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestation of Lyme disease. N Engl J Med. 1990;323(21):1438-44.10.1056/NEJM1990112232321022172819Search in Google Scholar

25. Mygland A, Skarpaas T, Ljostad U. Chronic polyneuropathy and Lyme disease. Eur J Neurol. 2006;13(11):1213-15.10.1111/j.1468-1331.2006.01395.x17038034Search in Google Scholar

26. Topakian R, Stieglbauer K, Nussbaumer K, Aichner FT.Cerebral vasculitis and stroke in lyme neuroborreliosis. Two case report and review of current knowledge. Cerebrovasc Dis. 2008;26(5):455- 61.10.1159/00015598218810231Search in Google Scholar

27. Charles V, Duprez TP, Kabamba B, et al. Poliomyelitis-like syndrome with matching magnetic resonance features in a case of Lyme neuroborreliosis. J NeurolNeurosurg Psychiatry. 2007;78:1160-61.10.1136/jnnp.2007.121103211755217878200Search in Google Scholar

28. Wilke M, Eiffert H, Christen HJ, Hanefeld F. Primarily chronic and cerebrovascular course of Lyme neuroborreliosis : case report and literature review. Arch Dis Child 2000;83(1):67-71.10.1136/adc.83.1.67171839910869004Search in Google Scholar

29. Kindstrand E, Nilsson BY, Hovmark A et al. Polyneuropathy in late Lyme neuroborreliosis - a clinical, neurophysiological and morphological description. ActaNeurol Scand. 2000;101:47-52.Search in Google Scholar

30. Hehir MK 2nd, Logigian EL. Infectious neuropaties. Continuum (Minneap Minn). 2014;20(5 Peripheral Nervous System Disorders):1274-92.10.1212/01.CON.0000455881.83803.a925299282Search in Google Scholar

31. Mygland A, Skarpaas T, Ljostad U. Chronic polyneuropathy and Lyme disease. Eur J Neurol. 2006;13:1213-15.10.1111/j.1468-1331.2006.01395.xSearch in Google Scholar

32. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol. 2007;49:13-21.10.1111/j.1574-695X.2006.00139.x17266710Search in Google Scholar

33. Tilea B,Tripon G, Voidazan S, Tilea I. Serological, clinical and epidemiological aspects of Lyme borreliosis in Mures County, Romania. Rev Romana Med Lab. 2014;22(2):233-34.Search in Google Scholar

34. LebechAM, Hansen K, Brandrup F, et al. Diagnostic value of PCR for detection of Borreliaburgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. MolDiagn. 2000;5:139-50.Search in Google Scholar

35. Ornstein K, Berglund J, Bergstrom S, et al. Three major LymeBorreliagenospecies (Borreliaburgdorferisensustricto, B. afzelii and B. garinii) identified by PCR in cerebrospinal fluid from patients with neuroborreliosis in Sweden .Scand J Inf Dis. 2002;34(5):341-46.10.1080/0036554011008031312069016Search in Google Scholar

36. Hashimoto Y, Takahashi H, Kishiyama K, et al. Lyme disease with facial nerve palsy: rapid diagnosis using a nested polymerase chain reaction- restriction fragment length polymorphism analysis. Br J Dermatol. 1998;138(2):304-9.10.1046/j.1365-2133.1998.02080.x9602880Search in Google Scholar

37. Ljostad U, Mygland A. CSF B- lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol. 2008;255:732-37.10.1007/s00415-008-0785-y18344056Search in Google Scholar

38. Rupprecht TA, Pfister HW, Angele B, et al. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurol. 2005;65(3):448-50.10.1212/01.wnl.0000171349.06645.7916087912Search in Google Scholar

39. Rupprecht TA, Kirschning CJ, Popp B, et al.Borreliagarinii induces CXCL13 production in human monocytes through Toll-like receptor 2. Infect Immun. 2007;75(5):4351-56.10.1128/IAI.01642-06195117917562761Search in Google Scholar

40. Stricker RB, Winger EE. Decreased CD57 lymphocyte subset in patients with chronic Lyme disease.ImmunolLett. 2001;76(1):43-48.Search in Google Scholar

41. Centrul national de Supravegheresi Control al BolilorTransmisibile-Boala Lyme metodologie de supraveghere: Lyme borreliosis available at http:// www.cnscbt.ro/index.php/metodologii/boala-lyme/10-boala-lymemetodologie-de-supraveghere-2014/fileSearch in Google Scholar

42. European Concerted Action on Lyme borreliosis-Diagnosis, treatment: Case Definition EUCALB available at http://eucalb.comSearch in Google Scholar

43. Karkkonen K, Stiernstedt SH, Karlsson M. Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis. Scand J Infect Dis. 2001;33(4):259-62.10.1080/00365540130007722511345216Search in Google Scholar

44. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurol. 2008;70(13):992-1003.10.1212/01.WNL.0000284604.61160.2d17928580Search in Google Scholar

45. Ayaslioglu E, Erkek E, Oba AA, CebeciogluE. Doxycycline- induced staining of permanent adult dentition. Aust Dent J. 2005;50:273-75.10.1111/j.1834-7819.2005.tb00373.x17016895Search in Google Scholar

46. Fallon BA, Levin ES, Schweitzer PJ, Hardesty D. Inflammation and central nervous system Lyme disease. Neurobiol Dis. 2010;37(3):534-41.10.1016/j.nbd.2009.11.01619944760Search in Google Scholar

47. Ljostat U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus ceftriaxone for European Lyme neuroborreliosis: a multicentric, noninferiority, double blind, randomised trial. Lancet Neurol 2008; 7(8):690-5. 10.1016/S1474-4422(08)70119-4Search in Google Scholar